Literature DB >> 14662972

Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients.

P Robinson1, R Carzino, D Armstrong, A Olinsky.   

Abstract

A 14-year-old boy with bronchiectasis secondary to chronic aspiration developed multiresistant Pseudomonas aeruginosa lower respiratory disease following several inpatient periods where accommodation and physiotherapy services were shared with cystic fibrosis (CF) patients known to be infected with the genetically identical strain of P. aeruginosa. Cross-infection with P. aeruginosa between CF patients and non-CF patients has not previously been described, and this finding raises significant issues relevant to the treatment of patients with non-CF suppurative lung disease.

Entities:  

Mesh:

Year:  2003        PMID: 14662972      PMCID: PMC309033          DOI: 10.1128/JCM.41.12.5741.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  2 in total

1.  Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

Authors:  K Cheng; R L Smyth; J R Govan; C Doherty; C Winstanley; N Denning; D P Heaf; H van Saene; C A Hart
Journal:  Lancet       Date:  1996-09-07       Impact factor: 79.321

2.  Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic.

Authors:  David S Armstrong; Gillian M Nixon; Rosemary Carzino; Andrea Bigham; John B Carlin; Roy M Robins-Browne; Keith Grimwood
Journal:  Am J Respir Crit Care Med       Date:  2002-10-01       Impact factor: 21.405

  2 in total
  8 in total

1.  Family case studies: absence of Pseudomonas aeruginosa transmission in bronchiectasis.

Authors:  Ruth Sobala; Kristian Brooks; John Davison; Joanna Lumb; Anthony De Soyza
Journal:  ERJ Open Res       Date:  2022-10-17

2.  A diagnostic PCR assay for the detection of an Australian epidemic strain of Pseudomonas aeruginosa.

Authors:  Heidi L Williams; Lynne Turnbull; Susan J Thomas; Anna Murphy; Tim Stinear; David S Armstrong; Cynthia B Whitchurch
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-07-16       Impact factor: 3.944

3.  Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.

Authors:  Pholawat Tingpej; Lucas Smith; Barbara Rose; Hua Zhu; Tim Conibear; Khaled Al Nassafi; Jim Manos; Mark Elkins; Peter Bye; Mark Willcox; Scott Bell; Claire Wainwright; Colin Harbour
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

4.  Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran.

Authors:  Z Movahedi; B Pourakbari; S Mahmoudi; F Sabouni; M T Ashtiani Haghi; R Hosseinpour Sadeghi; S Mamishi
Journal:  J Prev Med Hyg       Date:  2013-03

5.  Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.

Authors:  Laura J Sherrard; Anna S Tai; Bryan A Wee; Kay A Ramsay; Timothy J Kidd; Nouri L Ben Zakour; David M Whiley; Scott A Beatson; Scott C Bell
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

Review 6.  Risk of Bacterial Transmission in Bronchiectasis Outpatient Clinics.

Authors:  Philip Mitchelmore; Catherine Wilson; David Hettle
Journal:  Curr Pulmonol Rep       Date:  2018-07-02

Review 7.  Respiratory infections: a current and future threat.

Authors:  Grant Waterer; Richard Wunderink
Journal:  Respirology       Date:  2009-07       Impact factor: 6.424

Review 8.  Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications.

Authors:  Chooi Ling Lim; Chandramathi S Raju; Tooba Mahboob; Sunil Kayesth; Kamal K Gupta; Gaurav Kumar Jain; Mahaveer Dhobi; Muhammad Nawaz; Polrat Wilairatana; Maria de Lourdes Pereira; Jayanta Kumar Patra; Alok K Paul; Mohammed Rahmatullah; Veeranoot Nissapatorn
Journal:  Nanomaterials (Basel)       Date:  2022-01-12       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.